The recent release of the Patented Medicine Prices Review Board’s modernized regulatory framework will negatively impact Canada’s competitiveness in attracting investment to commercialize Canadian innovation.
Read More
BIOQuébec actively represents the interests of its members before political authorities. Here is a summary of the actions taken so far in 2019.
Read More